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Abstract: During the development of selective peptides against highly homologous targets,
a reliable tool is sought that can predict information on both mechanisms of binding and
relative afﬁnities. These tools must ﬁrst be tested on known proﬁles before application
on novel therapeutic candidates. We therefore present a comparative docking protocol in
HADDOCK using critical motifs, and use it to “predict” the various selectivity proﬁles of
several major KTX scorpion toxin families versus Kv1.1, Kv1.2 and Kv1.3. By correlating
results across toxins of similar proﬁles, a comprehensive set of functional residues can
be identiﬁed. Reasonable models of channel-toxin interactions can be then drawn that
are consistent with known afﬁnity and mutagenesis. Without biological information on
the interaction, HADDOCK reproduces mechanisms underlying the universal binding of
KTX-2 toxins, and Kv1.3 selectivity of KTX-3 toxins. The addition of constraints
encouraging the critical lysine insertion conﬁrms these ﬁndings, and gives analogous
explanations for other families, including models of partial pore-block in KTX-6. While
qualitatively informative, the HADDOCK scoring function is not yet sufﬁcient for accurate
afﬁnity-ranking. False minima in low-afﬁnity complexes often resemble true binding
in high-afﬁnity complexes, despite steric/conformational penalties apparent from visual
inspection. This contamination signiﬁcantly complicates energetic analysis, although it
is usually possible to obtain correct ranking via careful interpretation of binding-well
characteristics and elimination of false positives. Aside from adaptations to the broader
potassium channel family, we suggest that this strategy of comparative docking can beToxins 2012, 4 111
extended to other channels of interest with known structure, especially in cases where a
critical motif exists to improve docking effectiveness.
Keywords: protein-protein docking; scorpion toxins; Kv1.1; Kv1.2; Kv1.3; selectivity;
-KTx; HADDOCK; comparative docking
1. Introduction
The inhibition of potassium channels by peptides from animal venoms is a subject of broad interest
for its physiological and therapeutic applications [1]. The distribution of channels being ubiquitous and
varied, efﬁcient and safe targetting relies upon the selective binding of pharmacological agents to speciﬁc
subtypes involved. These include Kv1.3 and KCa3.1 in T-cell mediated diseases [2–4], Kv1.4 and 4.x in
neuropathic pain [5,6], and others.
There are many possible sources of channel-blocking peptides, including snakes [7], spiders [8],
scorpions [9], sea-anemones [10] and cone-snails [11], of which the most diverse collection currently
recorded are the KTX scorpion toxins [12] that target voltage-gated potassium channels (Kv). The
similarity of basic functional motifs across the various folding patterns is remarkable, indicating a strong
association with the particular characteristics of the channel surface. Moreover, these toxins also offer
a wide-range of afﬁnities against individual sub-types—a characteristic that underlies current efforts to
design pharmaceutically useful toxins.
The selectivity proﬁle of a given toxin is the primary property of interest in pharmaceutical design.
This has generally been studied in the context of Kv and KCa selectivity [13–16] as well as Kv1 subtype
selectivity. It is of great interest to construct a methodology that will assist in the prediction of a
toxin’s selectivity proﬁles, given its sequence and structure. This task can be ﬁlled by protein-protein
docking, which serves as a tool for the prediction and validation of functional residues in association with
mutagenesis studies. Studies involving docking combination with experiment include charybdotoxin
(ChTX) [17], iberiotoxin IbTX [16], Css20 [18], agitoxin-2 (AgTX2) [19], maurotoxin (MTX) and
Pi1 [20], ADWX-1 [21], cobatoxin-1 (coba-1) [22], and many others. The result from these various
works is an agreed set of motifs that determine general Kv-binding [1,9], although the exact motifs
governing subtype selectivity have not been fully elucidated.
Protein-protein docking programs [23] are numerous [24–27], and are being continually improved
by the community and tested in open avenues such as CAPRI [28]. The primary goal of
these programs is the correct prediction of bound complexes from the apo-conformations of its
constituents. Success currently depends on the representation of molecular ﬂexibility, whether in the
input-conformation(s)[29,30]orthedegreetowhichprotocolscanundertaketheﬂexibletransformations
required to move apo-states to holo-states [31,32]. Meanwhile, afﬁnity predictions from structure [33]
are usually the domain of more accurate formulations such as MM/PBSA and molecular dynamics [34].
The equivalent task in docking programs have been explored for small molecule binding [35–37], but
relatively few studies have been carried out at the protein-protein level.Toxins 2012, 4 112
In this work, we seek a uniﬁed protocol that can be applied to arbitrary toxin-channel pairs. This
report is a proof-of-principle application of the HADDOCK software for such purposes, tested against
the family of KTX-scorpion toxins. We seek to show by numerous examples the extent of information
that can be obtained by comparative docking: signiﬁcant contact-pairs, residue locations that exert
selectivity, and whether in-vivo afﬁnity can be predicted. The rat/mouse Kv 1.1, 1.2 and 1.3 channel
have been chosen as targets because of the comprehensive afﬁnity data available across the families
tested. We draw upon docking trials of over 25 KTx scorpion toxins against these channels, and three
conotoxins as control (see Table 1). Detailed methodology is provided in the hopes that the principles of
this methodology can be broadened to other channels of interest.
2. Methodology
All docking and MD simulations have been carried out with HADDOCK [25,38] and NAMD [39],
respectively. Visualisations of molecules and plots are in VMD [40], gnuplot, and xmgrace.
2.1. Conformer Preparations
Toxin coordinates listed in Table 1 have been assembled from the Protein Data Bank. MD-ensembles
have been generated for docking input, using the ﬁrst conformer from NMR-ensembles in 11-ns MD
simulations in NAMD under constant pressure and temperature (NPT)-conditions with 150 mM KCl.
Where docking using NMR-ensembles generate reasonable docking complexes, NMR-ensembles have
been used. Simulation-boxes for each equilibration is based on molecular volume followed by padding
with water of 10 ˚ A in each axis, resulting in  7000-atom systems. Frames were collected every 250 ps
over the last 8 ns, yielding 32 conformations.
Previous studies have identiﬁed afﬁnity changes of 3-fold with respect to C-terminal
amidation [41,42]. We have veriﬁed where possible the correct amidation states for toxins used in
experimental studies—but have otherwise assumed carboxylate forms for all synthetic sources.For
example, the structure of natively isolated noxiustoxin (NTX) is C-terminal amidated [43]. However,
this was removed in line with afﬁnity studies [44] that used a synthetic source [45] without amidation.
Channel coordinates for Kv1.1 and Kv1.3 have been prepared by taking the crystal structure of
Kv1.2-paddle chimera (2R9R.pdb [46]) and mutating necessary residues via the Mutator plug-in from
VMD. All histidines have been set as neutral, and protonated at N. The mutated channels have been
equilibrated in POPE-membrane under step-wise decreasing backbone and side-chain constraints, taking
place over 3 ns. Conformers were then collected in 200-ps intervals over a 6 ns unrestrained simulation
giving 31 conformations.Toxins 2012, 4 113
T
a
b
l
e
1
.
L
i
s
t
o
f
p
e
p
t
i
d
e
t
o
x
i
n
s
i
n
c
l
u
d
e
d
i
n
d
o
c
k
i
n
g
s
t
u
d
i
e
s
,
r
e
m
o
v
i
n
g
m
e
m
b
e
r
s
f
o
r
w
h
i
c
h
e
x
p
e
r
i
m
e
n
t
a
l
i
n
f
o
r
m
a
t
i
o
n
i
s
u
n
a
v
a
i
l
a
b
l
e
.
E
n
t
r
i
e
s
r
e
s
t
r
i
c
t
e
d
t
o
c
u
r
r
e
n
t
-
b
l
o
c
k
s
t
u
d
i
e
s
o
f
r
a
t
K
v
s
o
n
X
e
n
o
p
u
s
o
o
c
y
t
e
s
u
n
l
e
s
s
o
t
h
e
r
w
i
s
e
s
t
a
t
e
d
.
S
t
a
r
r
e
d
e
n
t
r
i
e
s
n
e
x
t
t
o
K
v
1
.
3
-
a
f
ﬁ
n
i
t
y
d
a
t
a
h
a
v
e
b
e
e
n
d
e
r
i
v
e
d
f
r
o
m
h
u
m
a
n
c
h
a
n
n
e
l
s
,
a
n
d
s
t
a
r
s
a
t
t
h
e
e
n
d
o
f
a
m
i
n
o
a
c
i
d
s
e
q
u
e
n
c
e
s
i
n
d
i
c
a
t
e
C
-
t
e
r
m
i
n
a
l
a
m
i
d
a
t
i
o
n
.
A
m
i
n
o
-
a
c
i
d
s
Z
a
n
d
O
i
n
d
i
c
a
t
e
5
-
o
x
o
p
r
o
l
i
n
e
a
n
d
4
-
h
y
d
r
o
x
y
p
r
o
l
i
n
e
,
r
e
s
p
e
c
t
i
v
e
l
y
,
a
n
d
h
a
v
e
b
e
e
n
p
a
r
a
m
e
t
r
i
s
e
d
m
a
n
u
a
l
l
y
f
o
r
d
o
c
k
i
n
g
a
n
d
m
o
l
e
c
u
l
a
r
d
y
n
a
m
i
c
s
.
T
h
e
p
u
t
a
t
i
v
e
p
o
r
e
-
L
y
s
i
s
b
o
l
d
e
d
i
n
e
a
c
h
s
e
q
u
e
n
c
e
.
F
a
m
i
l
y
-
I
D
A
l
i
a
s
S
e
q
u
e
n
c
e
A
f
ﬁ
n
i
t
y
,
n
M
S
o
u
r
c
e
s
K
v
1
.
1
K
v
1
.
2
r
K
v
1
.
3
1
.
1
C
h
T
X
-
-
-
Z
F
T
N
V
S
C
-
T
T
S
K
E
C
W
S
V
C
Q
R
L
H
N
-
T
S
R
G
K
C
M
N
K
K
C
R
C
Y
S
-
-
-
-
>
5
0
0
0
1
4
2
.
6
[
4
4
]
1
.
6
B
m
T
X
2
-
-
-
Z
F
T
N
V
S
C
-
S
A
S
S
Q
C
W
P
V
C
K
K
L
F
G
-
T
Y
R
G
K
C
M
N
S
K
C
R
C
Y
S
-
-
-
-
?
?
1
.
6
[
4
2
]
2
.
1
N
T
X
-
-
-
T
I
I
N
V
K
C
-
T
S
P
K
Q
C
S
K
P
C
K
E
L
Y
G
S
S
A
G
A
K
C
M
N
G
K
C
K
C
Y
N
N
-
-
-
>
2
5
2
1
[
4
4
]
2
.
2
M
g
T
X
-
-
-
T
I
I
N
V
K
C
-
T
S
P
K
Q
C
L
P
P
C
K
A
Q
F
G
Q
S
A
G
A
K
C
M
N
G
K
C
K
C
Y
P
H
-
-
-
0
.
1
4
4
0
.
6
7
5
0
.
2
3
[
4
7
]
2
.
5
H
g
T
X
1
-
-
-
T
V
I
D
V
K
C
-
T
S
P
K
Q
C
L
P
P
C
K
A
Q
F
G
I
R
A
G
A
K
C
M
N
G
K
C
K
C
Y
P
H
-
-
-
0
.
0
3
1
0
.
1
7
0
.
0
8
6
[
4
7
]
3
.
1
K
T
X
-
-
G
V
E
I
N
V
K
C
-
S
G
S
P
Q
C
L
K
P
C
K
D
A
-
G
-
M
R
F
G
K
C
M
N
R
K
C
H
C
T
P
K
-
-
-
1
.
1
2
5
0
.
1
[
4
4
]
3
.
2
A
g
T
X
2
-
-
G
V
P
I
N
V
S
C
-
T
G
S
P
Q
C
I
K
P
C
K
D
A
-
G
-
M
R
F
G
K
C
M
N
R
K
C
H
C
T
P
K
-
-
-
0
.
0
4
4
2
7
0
.
0
0
4
[
4
8
,
4
9
]
3
.
6
B
m
K
T
X
-
-
-
V
G
I
N
V
K
C
-
K
H
S
G
Q
C
L
K
P
C
K
D
A
-
G
-
M
R
F
G
K
C
I
N
G
K
C
D
C
T
P
K
*
-
-
?
?
0
.
2
[
4
2
]
3
.
6
m
u
t
A
D
W
X
-
1
-
-
-
V
G
I
N
V
K
C
-
K
H
S
R
Q
C
L
K
P
C
K
D
A
-
G
-
M
R
F
G
K
C
T
N
G
K
C
H
C
T
P
K
-
-
-
0
.
6
5
>
1
0
0
0
.
0
0
2
[
2
1
]
3
.
7
O
s
K
-
-
G
V
I
I
N
V
K
C
-
K
I
S
R
Q
C
L
E
P
C
K
K
A
-
G
-
M
R
F
G
K
C
M
N
G
K
C
H
C
T
P
K
-
-
-
0
.
6
5
.
4
0
.
0
1
4
[
5
0
]
3
.
7
m
u
t
A
O
s
K
-
-
G
V
I
I
N
V
K
C
-
K
I
S
R
Q
C
L
K
P
C
K
D
A
-
G
-
M
R
F
G
K
C
M
N
G
K
C
H
C
T
P
K
-
-
-
0
.
4
2
.
9
6
0
.
0
0
3
[
5
0
]
4
.
1
T
s
T
X
-
K

-
-
-
V
F
I
N
A
K
C
-
R
G
S
P
E
C
L
P
K
C
K
E
A
I
G
-
K
A
A
G
K
C
M
N
G
K
C
K
C
Y
P
-
-
-
-
>
1
0
0
0
0
.
5
5
3
.
9
[
5
1
,
5
2
]
6
.
1
P
i
1
-
-
-
-
-
-
L
V
K
C
-
R
G
T
S
D
C
G
R
P
C
Q
Q
Q
T
G
C
-
P
N
S
K
C
I
N
R
M
C
K
C
Y
G
C
-
-
-
>
5
0
0
0
0
.
4
4
>
5
0
0
0
N
B
:
M
a
x
-
b
l
o
c
k
i
s

5
5
%
.
[
5
3
]
6
.
2
M
T
X
-
-
-
-
-
-
-
V
S
C
-
T
G
S
K
D
C
Y
A
P
C
R
K
Q
T
G
C
-
P
N
A
K
C
I
N
K
S
C
K
C
Y
G
C
*
-
-
4
5
,
>
1
0
0
0
0
.
5

1
1
8
0
,
1
5
5
[
5
4
]
M
a
x
b
l
o
c
k
i
s
7
0
[
5
5
]

1
0
0
[
5
6
]
%
v
s
.
K
v
1
.
2
a
n
d
>

2
0
%
v
s
.
K
v
1
.
3
.
3
.
2
/
6
.
2
A
g
T
X
2
/
M
T
X
-
-
G
V
P
I
N
V
S
C
-
T
G
S
K
D
C
Y
A
P
C
R
K
Q
T
G
C
-
P
N
A
K
C
I
N
K
S
C
K
C
Y
G
C
-
-
-
?
0
.
1
4
?
[
4
9
]
1
2
/
6
.
2
B
u
T
x
/
M
T
X
W
C
S
T
C
L
D
L
A
C
-
T
G
S
K
D
C
Y
A
P
C
R
K
Q
T
G
C
-
P
N
A
K
C
I
N
K
S
C
K
C
Y
G
C
-
-
-
?
0
.
1
3
?
[
5
7
]
6
.
2
/
6
.
3
M
T
X
/
H
s
T
x
1
-
-
-
-
-
-
-
V
S
C
-
T
G
S
K
D
C
Y
A
P
C
R
K
Q
T
G
C
-
P
Y
G
K
C
M
N
R
K
C
K
C
N
R
C
-
-
-
1
>
1
0
0
4
[
5
4
]
6
.
3
H
s
T
X
1
-
-
-
-
-
-
-
A
S
C
-
R
T
P
K
D
C
A
D
P
C
R
K
E
T
G
C
-
P
Y
G
K
C
M
N
R
K
C
K
C
N
R
C
*
-
-
7
>
1
0
0
0
.
0
1
1
[
5
8
]
6
.
4
P
i
4
-
-
-
-
I
E
A
I
R
C
-
G
G
S
R
D
C
Y
R
P
C
Q
K
R
T
G
C
-
P
N
A
K
C
I
N
K
T
C
K
C
Y
G
C
S
-
-
>
1
0
0
0
0
0
.
0
0
8
>
1
0
0
0
0
N
B
:
M
a
x
-
b
l
o
c
k
i
s

6
0
%
.
[
5
9
]
7
.
1
P
i
2
-
-
-
-
-
-
T
I
S
C
-
T
N
P
K
Q
C
Y
P
H
C
K
K
E
T
G
Y
P
N
-
A
K
C
M
N
R
K
C
K
C
F
G
R
-
-
-
?
0
.
0
3
2
*
0
.
0
5
0
[
6
0
,
6
1
]
1
0
.
1
C
o
b
a
1
-
-
-
-
-
-
-
A
V
C
-
V
-
Y
R
T
C
D
K
D
C
K
R
R
-
G
-
Y
R
S
G
K
C
I
N
N
A
C
K
C
Y
P
Y
-
-
-
2
4
4
0
0
2
7
5
3
0
0
[
2
2
]
D
e
s
.
m
o
k
a
-
1
-
-
-
-
-
I
N
V
K
C
-
S
L
P
Q
Q
C
I
K
P
C
K
D
A
-
G
-
M
R
F
G
K
C
M
N
K
K
C
R
C
Y
S
-
-
-
-
¿
1
0
0
0
6
2
0
*
1
[
6
2
]Toxins 2012, 4 114
2.2. Methods of Analysis
In an effort to apply our methodology across the broadest subset of toxins, we have used
characteristics common to KTx toxins as parameters to analyse docking results: (1) a side-chain
lysine that inserts into the ion-conducting pore (pore-Lys), and (2) the -sheet covering residues between
2-upstream and 9-downstream of pore-Lys that must be in contact for this insertion to occur. As pore-Lys
insertion is a common characteristic amongst KTx toxins [9,63], we deﬁne a distance between its amine
and the centre of the plane formed by tyrosine carbonyls in the selectivity ﬁlter (TVGYG). The length
and strand-turn-strand secondary structure of the -sheet is also conserved in all of the KTx toxins
studied, along with locations of hitherto known functional residues. This forms a suitable common
RMSD-reference for toxins and removes the performance bias associated with top-complex RMSDs in
individual docking trials. The reference coordinates have been taken from the NMR-based structure of
KcsAmut with bound ChTX [64], and we will refer to this measure as the “-sheet C RMSD” for the
rest of this report.
2.3. Docking Protocols
Weconstructtwogeneralscenariosunderwhichadockingprogramislikelytobeused: blind-docking
and binding site reﬁnement. The former takes place when binding site information is generally unknown,
and docking is used as a source of inspiration for further experimental validation, while the latter
is a converse scenario where some information is known (usually through partial mutagenesis data)
and docking is used to visualise this and provide further insights to the interaction. In blind trials,
20,000 initial rigid body complexes are generated with randomised ambiguous interaction restraints
(AIRs) determined by HADDOCK. Conformers are selected systematically in order to represent all
possible pairings. The top-200 initial encounter-complexes by HADDOCK-energy are then reﬁned in
simulated-annealing, split into sidechain-ﬂexible stages and all-atom ﬂexible stages in explicit solvent.
Re-ranking of these reﬁnements give the results of docking.
In scenarios of binding-site reﬁnement, we have assumed prior knowledge of the lysine-insertion
motif and deﬁned a set of constraints and additional considerations to aid in docking. A set of 3
˚ A-distance restraints is created using pore-Lys as the centre of the interaction surface, with reference
to the terminology of “active” and “passive” residues as deﬁned by HADDOCK. Active residues
(i.e., residues with explicit restraints) span pore-Lys and two additional residues nearby (2-upstream
and 2-downstream along the -sheet). Although pore-Lys forms hydrogen-bonds with the tyrosine
carbonyls separating the S0/S1 ion binding-sites in the ﬁlter, this residue is largely buried and cannot
act as an effective restraint. Therefore, we include glycines at the end of the selectivity ﬁlter as active
residues. Passive residues (potential partners of restraints) include all physically-adjacent residues of
active residues.
In terms of test and production runs, 5000 initial rigid-body complexes are generated and the top-200
selected for further reﬁnement as above. Channel symmetry has been included in docking after spurious
observations of misalignment between monomers—these constraints consist of four C2-symmetry pairs
binding opposing P-helices and the top half of S6-helices, separately. C4-symmetry has not been
implemented in HADDOCK at the time of testing. Ion and water occupancy at crystallographicToxins 2012, 4 115
coordinates were also considered, assuming the canonical high conductivity states of S0/S2/S4 or S1/S3,
then removing waters/ions at S0 and S1 to facilitate pore-Lys insertion. This includes crystallographic
waters found behind the selectivity ﬁlter. Docking runs utilising all of the above considerations will be
described as “optimal” in this study.
3. Results and Discussion
3.1. Channel Morphology
Before exploring the details of toxin-channel interactions, it is important to remind ourselves of the
unique characteristics of the channel surface. To give a spatial understanding of this, we show an
MD-snapshot of the three Kv1-channels in Figure 1 and list their sequences in Table 2. All residue
numberings will be according to Kv1.2 for consistency. The most critical characteristic to note is the
relative size of turret residues at positions 353–359, and in particular 357 and 381 most proximal to the
pore. Kv1.3 presents a broad and shallow surface for toxin-binding (G357 and H381), while Kv1.1’s
vestibule is signiﬁcantly narrowed by bulky residues H357 and Y381. We note that the role of external
space in selectivity has been previously examined between Kv1.3 and KCa1.1 channels [15], and will also
apply such considerations to this study.
Figure 1. Exterior view of the Kv1 channels, highlighting the differences in morphology and
residue types. Sidechains of exposed basic (blue), acidic (red) and aromatic residues (green)
have been given coloured spheres to indicate the nature of potential interactions. Surface
calculated by MSMS at 3 ˚ A 2 density and 1.5 ˚ A probe radius and rendered with ambient
occlusion by Tachyon in VMD before post-processing.
(a) Kv1.1 surface (b) Kv1.2 surface (c) Kv1.3 surface
It should also be noted that the net charge of the entire exterior is either -20 (Kv1.1), or -16 (Kv1.2
and Kv1.3), taking into account that the pKa of histidines are not signiﬁcantly affected according to
propKa calculations [65]. We therefore expect to ﬁnd non-speciﬁc binding by most toxins due to their
net positive charge.Toxins 2012, 4 116
Table 2. Sequence extract of Kv1-channels used in this work from the top-half of TM5,
pore-helix, selectivity ﬁlter, to the top-half of TM6. The residue numbering have been
matched to rat Kv1.2 (i.e., 2A79.pdb).
Channel Extract of TM1-TM2 or TM5-TM6 sequence
Kv1.1 ...SSAVYFAEAEEAESHFSSIPDAFWWAVVSMTTVGYGDMYPVTIGGKIVGS...
Kv1.2 ...SSAVYFAEADERDSQFPSIPDAFWWAVVSMTTVGYGDMVPTTIGGKIVGS...
Kv1.3 ...SSAVYFAEADDPSSGFNSIPDAFWWAVVTMTTVGYGDMHPVTIGGKIVGS...
3 3 3 3 3
5 6 7 8 9
Residue numbering 34567890123456789012345678901234567890123456789012345
3.2. Complex Selection and Ordering of Results
In order to minimise bias in the validation, we devised a set of general criteria that was used to select
the complexes shown in this report. Likewise, trends of afﬁnity and experimental mutagenesis studies
have been purposefully excluded (as much as we are capable thereof). The conditions for complex
selection are thus:
(1) That the complex is correctly assembled. The channel assembly are sometimes distorted in
order to satisfy docking constraints, whether in random blind-trials or explicitly given. The program
limitations prevent a proper modelling of the membrane environment, which translates into dilation of
the Kv-monomers and destruction of selectivity ﬁlter sites. We judge this perturbation via the separation
of opposing monomers and the positions of crystallographic ion and waters in the ﬁlter, and prefer
complexes with minimal or no perturbations.
(2) That the secondary/tertiary structures are not signiﬁcantly distorted. Across the entire dataset, we
observedasimilartendencyforcomplexestomaximisecontactinterfacesatasacriﬁceofconformational
integrity. This often appears as a partial loss of toxin secondary structure associated with very deep
interactions of sidechain moieties. We believe that this is a by-product of HADDOCK design philosophy
that maximises effectiveness of the binding-site search, and will show later in this report that such
tendencies can lead to false positives where toxins distort themselves in order to ﬁt into binding modes
otherwise not possible.
(3a) That the chosen complex be a member of a cluster, and where multiple clusters are available,
the largest and energetically-favoured cluster. The essence of docking being stochastic, repeatability of
results is a primary conﬁrmation of success. This criterion should excludes isolated outliers that appear
at signiﬁcantly lower energies than the main cluster.
(3b) That the chosen complex be of a low energy member of its cluster, and representative of the
overall interactions observed within the cluster. The docking protocol implemented rarely optimises
every aspect of the interaction in question, and many complexes exhibit subsets of the interactions that
are possible for the binding mode in question. We choose one that shows best the characteristics of the
cluster.
Due to the large number of toxins and the similarity of observations within several families, we
will group these discussions by KTx family IDs and sequence homology. As the family-1 toxins areToxins 2012, 4 117
generally stronger binders to KCa-channels, we will not discuss them in this report. We will instead begin
with the KTx-2 family that is generally effective against all three Kv-subtypes.
3.3. KTx-2
The tested family-2 toxins comprise three toxins: noxiustoxin (NTX, KTx-2.1), margatoxin (MgTX,
2.2), and hongotoxin (HgTX1, 2.5). The latter two bind to tested Kv-channels at pM afﬁnity, while NTX
bind at nM afﬁnity and does not interact strongly with Kv1.1. We will show the results of blind and
constrained trials for NTX and MgTX in Figure 2. The docking performances of HgTX1 resemble that
of MgTX and are therefore not shown here.
The general performance of HADDOCK is visually represented by sorting complexes according
to pore-Lys insertion, -sheet RMSD and HADDOCK-energy. Potential native complexes are
therefore near the bottom-left border, which show low separation of pore-Lys from the pore. MgTX
constrained-dockings (Figure 2a–c) show visible clustering of complexes near the expected result—the
top-ten complexes are relatively close and surrounded by a funnel in the energy surface, although they
are not always members of the same cluster. When supported by contact analysis, these observations
suggest that the toxin is a good binder.
The net effect of constraints is to heavily concentrate searches around a putative binding orientation.
Although sparsely populated, similar conﬁgurations are found between the best blind and best
constrained complexes. It is interesting to note that blind results (i.e., without search bias) for NTX
results yield fewer canonical binding than picomolar binders MgTX and HgTX2, and moreover, none
of the top-complexes vs. Kv1.1 are canonical (compare Figure 1(i) with 1(l)). This is suggestive of
some correlation between afﬁnity and docking success as measured by hit frequency. It also implies that
constraints may force ligands to bind where it should not—an assumption that will need to be tested
for novel toxins. We will return to this topic when discussing potential afﬁnity predictions. For now,
we also note that conformational distortions are more common in Kv1.1 complexes, particularly for the
forced NTX example. This is evidence of a possible false-positive, and we will conﬁrm this with more
examples in other families.
The complexes vs. all three channels in this family reside at similar -sheet RMSD. This is because
the modes are super-imposable (Figure 3). MgTX and HgTX1 share a common binding mode that
emphasises contact with conserved residues E/D353, D363 and D379 via basic-ring residues such as
K11, K35 and H38 (likely charged due to its proximity with several carboxylic moieties). The addition
of R24 in HgTX1 increases the net afﬁnity relative to MgTX, from its additional salt-bridge without
signiﬁcantly perturbing the binding mode.
Are there any other residues that deﬁne the characteristics of family-2? The contacts of the -sheet
are small up-stream of pore-Lys K28 (SAGAK), and large downstream (KCMNGKCKCYPH). This
combination forms a relatively ﬂat interface that encourages a centralised location over the conducting
pore. Such a position brings maximum weight to the inﬂuence of position 381—where Kv1.1’s Y381
should constitute the greatest source of perturbation—and decreases the contribution of turret residues to
selectivity. This reasoning applies in particular to NTX, whose helices lack the double proline P15/P16
that allows MgTX and HgTX1 helices to bend and accommodate Y381. The destabilisation of the
common binding mode is most evident in the inability of Kv1.1–NTX blind-trials to identify this mode,Toxins 2012, 4 118
Figure 2. Comparison between constrained- and blind-docking data for two members
of KTX-2, margatoxin (MgTX, 1MTX.pdb) and noxioustoxin (NTX, 1SXM.pdb).
Constraineddockingresultsarepresentedinthe1stand3rdrows, whileblinddockingresults
are in rows 2 and 4. Colours red, green and blue correspond to Kv1.1, Kv1.2, and Kv1.3
complexes, respectively. Numbers 1–10 above the dots indicate the rank of the complex at
that conﬁguration.
(a) Kv1.1—MgTX (b) Kv1.2—MgTX (c) Kv1.3—MgTX
(d) Kv1.1—MgTX (e) Kv1.2—MgTX (f) Kv1.3—MgTX
(g) Kv1.1—NTX (h) Kv1.2—NTX (i) Kv1.3—NTX
(j) Kv1.1—NTX (k) Kv1.2—NTX (l) Kv1.3—NTXToxins 2012, 4 119
and the signiﬁcantly increased frequency of distortion in results. NTX also possesses the mutation
H39N, which is a loss of charge that may be the explanation for a decreased afﬁnity relative to MgTX
and HgTX1.
Figure 3. Superimposed chosen Kv-docked complexes of the family-2 toxins from
constrained results. Colours red, green and blue correspond to Kv1.1, Kv1.2, and Kv1.3
complexes, respectively. Labelled residues indicate charged elements that interact (< 5 ˚ A)
with the channel in either all three cases (black) or two out of three cases (grey). Isolated
charge contacts are labelled by colour of complex. Numbers after labels indicate the actual
complex selected as sorted by HADDOCK energy, in the same order. Other interacting
residues have been left unlabelled for simplicity.
(a) NTX: #14, #3, #2 (b) MgTX: #2, #2, #3 (c) HgTX1: #7, #2, #1
3.4. KTx-4
We will now turn to family-4, whose -sheet similarity is closest to family-2. Tityustoxin-K 
(TsTXK, 4.1) exhibits a weak Kv1.2 preference over Kv1.3, but like NTX it does not bind Kv1.1.
Docking for this toxin reveals two competing modes at 2.5 and 4.5 ˚ A RMSD for both Kv1.2 and
Kv1.3 (Figure 4). Although we choose to present a Kv1.2 complex from the 4.5 ˚ A cluster based
on cluster size and frequency, complex #1 conformations (2.5 ˚ A) are very similar for both channels.
It is important to note that we again observe analogous binding modes vs. Kv1.1, despite the lack
of experimental afﬁnity. The complex shown (#5) for this channel is a marginally-acceptable model,
intended to illustrate the kind of toxin distortions that may be found for conﬂicting pairings.
The presence of two modes appears to be a product of increased symmetry and toxin size. The 2.5 ˚ A
mode favoured by Kv1.3 emphasises charge interactions with D379s by K23 and K34, and an extended
toxin-conformation with the -helix pulled closer to the channel exterior. As a whole, contact pairings of
this mode are similar to the modes found for KTx-2 toxins. On the other hand, the 4.5 ˚ A mode favoured
by Kv1.2 emphasises basic-ring interactions with turret charges. TsTXK’s shorter -sheet and smaller
constituent amino-acids permits this rotated mode, where we observe mirror pairs such as S10/Y36,
V1/K16 and K18/K32 that interact with equivalent residues on two opposing channel monomers. TheToxins 2012, 4 120
two modes found by HADDOCK are thus related by a rotation of 30–45 degrees along the channel axis
in connection with the relative displacement of these residues.
The potential existence of multiple modes becomes more reasonable if we study the symmetry
properties of the interaction. The basic-ring distributions of many toxins mimic the channel’s tetrameric
nature. Likewise, H-bonding partners such as S10 and Y36 form opposing pairs that bind to backbone
carboxyls. On the channel, position 355 is marginally farther from the pore than D379, which means
the inclusion of a negative charge here increases the charge symmetry to 8-fold. Where permitted by
the toxin’s geometry (i.e., a favourable match with residue 381) this favours modes where the toxin
is capable of exploiting charges on the turret, whereas its replacement S355 in Kv1.3 offers only
H-bonding stabilisation.
Figure 4. Constrained-docking results for KTx-4 member tityustoxin-K  vs. Kv1.1 (red),
Kv1.2 (green) and Kv1.3 (blue). (a–c) HADDOCK Energy plots against pore-Lys distance
and -sheet RMSD with 2A9H.pdb. (d–f) Selected complexes are shown as a visual aid to
docked conformations.
(a) Kv1.1—TsTXK (b) Kv1.2—TsTXK (c) Kv1.3—TsTXK
(d) complex #5 (e) complex #2 (f) complex #1
Given the accuracy limits of docking, the small separation in energy of the two clusters is probably
not sufﬁcient evidence to conﬁdently assert that TsTXK does bind in different orientations to the two
channels. The above analysis can be conﬁrmed by mutagenesis of residues that preferentially affect one
mode over the other, such as G9 and K23 to reduce Kv1.3 binding, or an insertion of a -sheet residue
to destabilise the rotated Kv1.2 mode.Toxins 2012, 4 121
3.5. KTx-3
The tested KTx-3 toxins number six: kaliotoxin (KTX, 3.1), Agitoxin-2 (AgTX2, 3.2), BmKTX
(3.6), ADWX-1 (3.6mut), OsK1 (3.7), and AOsK1 (3.7mut). All of these toxins display strongest
experimental binding to Kv1.3 channels, of which ADWX-1 and AOsK1 are rationally designed mutants
and have putatively improved selectivities or afﬁnity for Kv1.3. We will focus our discussion on
ADWX-1, AOsK1, and AgTX2 for the sake of brevity and state simply that the other three toxins show
similar docking performance and binding conﬁgurations.
As these toxins are generally low-picomolar binders to Kv1.3, we tested whether blind-docking
is sufﬁcient to isolate putative binding orientations (Figure 5). Docking performance is generally
acceptable and ranks complexes with canonical pore-Lys insertion well. Where found, the majority of
canonical complexes vs. Kv1.3 and some complexes vs. Kv1.1 share the interaction of R23/24( 3)
with the channel cleft near D363, in addition to pore-Lys. This feature is conﬁrmed in all
constrained-dockings with clustering around similar complexes (shown for ADWX-1 in Figure 7 later).
AOsK1 docking with NMR-conformations appears to also bind with the N-terminal proximal to the
pore, as indicated by a distant cluster on the energy surface. The same phenomenon is also observed in
AgTX2 docking with NMR conformations (not shown) but reduces when MD-equilibrated conformers
are used. These observations lead us to believe that biases in the initial-conﬁguration can lead to large
differences in blind-docking. (We discuss such biases in another submitted publication.) Here, we will
take the canonical complexes from blind-docking for further analysis.
ComparedwiththeKTx-2MgTX,theKTx-3bindingsiteisshiftedawayfromtheporetowardsthe
cleft (downwards in diagram). We suggest this is the net effect of the changes on the -sheet (MRFGK).
The transfer of the dyad aromatic Y36(+9) to F25( 2) and addition of M( 4) and R( 3) creates a
ridge on the upstream -strand that is more suited to the cleft between turrets. R( 3) and charges at the
C-terminal constructs an ionic network with D363, D379 and K388(A structural zwitterionic lipid is also
located here and participates in the network, although we did not include it in docking). These features
lock the toxin to the location shown in Figure 5j–l. Notably, the location of F2 is pressed against the
channel surface—we suspect that this is one of the primary causes of selectivity. It is co-located with
position 381 in AgTX2 and AOsK1, but is shifted counter-clockwise to a groove between ﬁlter residues
in ADWX-1. The energetics of two clusters are again not very well separated except for Kv1.3, which
leads to some doubt on the accuracy of exact details. However, constrained docking does conﬁrm that
the modes are distinct and energetically favoured for the respective toxins mentioned.
On the other side of the toxin, we observe proximity of residues both upstream of the helix and at the
-turn with the channel turrets. In ADWX-1 these are H9, T29 and N30, which appear to exert strong
selectivity effects—the Kv1.2 binding mode shows signiﬁcant shifting in contact pairs. In AgTX2 and
AOsK1, H9 and T29 are replaced by G10/I10 and M30, respectively. These differences may explain
the non-afﬁnity for Kv1.2–ADWX-1 binding via the presence of steric clashes and alternation of local
interactions. Therefore, mutations at this half of the toxin are likely to alter the net selectivity without
destroying the basic characteristics of KTx-3.Toxins 2012, 4 122
Figure 5. Blind docking data for three family-3 toxins. Colours red, green and blue
correspond to Kv1.1, Kv1.2, and Kv1.3 complexes, respectively. Subscripts of the toxin
show the source input ensembles used in docking. (a–i) Energy, RMSD and lysine insertion
for toxin and channel pairs; (j–l) Superimposed images of chosen complex according to
lowest HADDOCK energy with correct lysine-insertion. Labelled residues indicate charged
elements that interact with the channel in all three cases (< 5 ˚ A), although not necessarily at
the same location. Pore-inserting lysine is unlabelled for simplicity.
(a) Kv1.1—ADWX-1 (b) Kv1.2—ADWX-1 (c) Kv1.3—ADWX-1
(d) Kv1.1—AOsK (e) Kv1.2—AOsK (f) Kv1.3—AOsK
(g) Kv1.1—AgTX2 (h) Kv1.2—AgTX2 (i) Kv1.3—AgTX2
(j) ADWX-1NMR overlap (k) AOsKNMR overlap (l) AgTX2MD overlapToxins 2012, 4 123
Other basic-ring members are usually associated with turret charges rather than D363/D379, in
contrast with family-2 basic-rings. If the general mode found here is correct, then it may be possible to
enhance Kv1.3 preference by replacing some members with polar residues. Using AOsK1 as a template
sequence, G1, K9, K19, and K32 binds E/D355 in the four monomers of Kv1.1 and 1.2, respectively.
This equivalent position is S355 in Kv1.3, which implies that the loss of salt-bridging while preserving
H-bonding will disfavour other Kv-binding without affecting Kv1.3 binding adversely.
As it is still unclear whether some channel–toxin interactions possess multiple modes, these
predictions may be somewhat simplistic. Docking has produced several related minima that share the
main R( 3) anchoring, from which we simply choose the one that appears to be most reasonable for
the purposes of this study. It is possible that after eliminating one mode through mutation, some afﬁnity
is preserved via a less-favoured but unobstructed mode. Such complexities increase the difﬁculty of
building mutant-binding correlations, although the relationship between these modes can be investigated
with more accurate computational methods.
3.6. KTx-6
The family-6 toxins have been grouped together due to the presence of an extra disulphide bond,
although different selectivity patterns have been observed in its members. This extra pair is commonly
found as an additional connection between the C-terminal and the helix-sheet loop upstream of pore-Lys
(C1C5-C2C6-C3C7-C4C8), with the exception of maurotoxin (MTX, 6.2) whose network becomes
C1C5-C2C6-C3C4-C7C8. We will split the following discussion into Kv1.2-selective peptides (Pi1,
Pi4, and MTX) and Kv1.1/1.3-selective peptides (HsTX1). The various chimeric constructs based on
MTX have been tested in blind-docking but not included in this report, as analysis has been hampered
by unorthodox folding in the starting structures.
The majority of peptides in family-6 possess the greatest afﬁnity to Kv1.2: Pi1 (6.1), MTX, and Pi4
(6.4). It is interesting to note, however, that the maximum current block was shown to be 60% at +70
mV depolarisation—indicating some form of partial pore-blocking mechanism. Constrained-docking
was carried out for these toxins, which yielded displaced bound positions relative to the pore entrance.
The selection of complexes for Pi1 and Pi4 (Figure 6) shows toxins that are tilted towards their helices
as a result of the numerous charge contacts there. This results in a partial exposure of the pore vestibule
near K30/32(+7) where the inserted pore-Lys is directly visible (Figure 5(b) and 5(e)) Pi1 is stabilised
by K3, R5, T7, S8, R12 and Q16 through numerous polar and charged contacts, and Pi4 increases the net
afﬁnity through the mutation S8-R10. These are mainly in contact with D355, Q357, and T383 unique
to Kv1.2, in addition to shared moieties such as E/D353. The opposite half on the -sheet is supported
only by Y(+9)–N357 and a charge or H-bond contact through K/R(+4). Again, we note that this slanted
mode has also been observed in other channels, although very little current block has been observed in
experimental studies.Toxins 2012, 4 124
This lop-sided system may explain the partial block observed in current-block studies. It is known
that the pore-Lysine site is in competition with extracellular K+ [66,67], and the contacts are relatively
weak on the side that partially exposes the ﬁlter. We hypothesise that at positive potentials the weak
contacts can break, resulting in a partial unbinding of the toxin and subsequent K+-efﬂux (Figure 5(g)).
A maximum block of <100% is explicable by an equilibrium between a bound, pore-occluding mode
and a bound, open-pore mode. The numerous contacts along the -helix spotted in docking provides
potential mechanisms where the toxin may remain in close proximity to the pore.
What of MTX? Its experimental data appears to be more complicated. We note that Kharrat et al.
shows 100% block at depolarisation of 0 mV, while Fajloun et al. shows 80% block at depolarisation
of 70 mV, both on Xenopus oocytes in low exterior K+. This presents us with certain difﬁculties as to
which data to use in interpretation. Nevertheless, we ﬁnd a centralised position of MTX compared to
the other two toxins. The removal of K3, R5 and R12 and placement of K7 returns the lop-sided nature
of contacts elsewhere. K7 and R14 have been conﬁrmed in double mutant cycles [68] to interact with
D355, and we observe their direct contacts in Figure 5(h).
As noted above, the HsTX1 (6.3) selectivity proﬁle is the opposite of that observed for other members.
A complete renovation of the interface is apparent (Figure 7): contacts granted by K28, N32 and R33
ﬁxes the -sheet side of the toxin strongly and places the dyad aromatic Y21( 2) in direct contact with
the channel turret of Kv1.3. We elected to include the binding modes for ADWX-1 and mokatoxin
to illustrate the similarities of the Kv1.3 mode despite the difference in amino-acid sequences. The
particular orientation suggests that the mechanisms of selectivity for Kv1.3 over other channels are
broadly similar, and already described for KTx-3 toxins. The occupancy of residues next to the
critical 355 and 357 turret-positions confer local H-bonding as well as surface matching, be it from
the asparagine at the (+3)-position [15], Y21( 2) in HsTX1, H9 in ADWX-1, or the double aromatic
dyad motif F( 2) and Y(+9) in mokatoxin. It would therefore appear that the same lessons learnt in
KTx-3 binding can apply to these other toxins, and modiﬁcations such as shifting or removing basic
ring members not directly beneﬁcial to Kv1.3-binding will optimise the selectivity-ratio of any similar
toxin. Within the bounds of this binding mode, only the charges in its 4-fold symmetry appears to
be necessary.
Binding is again observed vs. Kv1.2 where HsTX1 is ineffective up to 100 nM. (A hairline decrease
in current is seen in the study proper at 100 nM.) Unlike KTx-3 toxins where many of the contacts are
merely shifted, the position is rotated counterclockwise to a turret-to-turret orientation. Here, HsTX1
loses much of the polar contacts but keeps its charges with new turret pairs. We hypothesise that binding,
if present, may be detectable at micromolar concentrations.Toxins 2012, 4 125
Figure 6. Selected complexes from Kv1.2-selective members of KTx-6, providing different
views of the interaction. The toxin and channel have been displayed with spheres and
surfaces to emphasise the spatial volume of the interaction, and an overview of peripheral
contacts is presented. (g) Hypothetical model to explain a maximum block of <100% in
this!family.
(a) Kv1.2—Pi1, #4 top view (b) Kv1.2—Pi1, #4 side view (c) Kv1.2—Pi1, #4 contacts
(d) Kv1.2—Pi4, #2 top view (e) Kv1.2—Pi4, #2 side view, some
channel residues removed
(f) Kv1.2—Pi4, #2 contacts
(g) Partial occlusion model (h) Kv1.2—MTX, #11 top viewToxins 2012, 4 126
Figure 7. Comparison of docking modes between KTx-6 HsTX1, KTx-3 ADWX-1, and
combinatorial toxin moka-1 vs. Kv1.1 (red), Kv1.2 (green) and Kv1.3 (blue). Toxin residues
in contact with the channel have been shown in coloured spheres to visualise the spatial
properties in binding.
(a) Kv1.1—HsTX1 complex #11 (b) Kv1.2—HsTX1 complex #4 (c) Kv1.2—HsTX1 complex #1
(d) Kv1.1—ADWX-1 complex #3 (e) Kv1.1—ADWX-1 complex #3 (f) Kv1.1—ADWX-1 complex #2
(g) Kv1.1—moka-1 complex #1 (h) Kv1.1—moka-1 complex #8 (i) Kv1.1—moka-1 complex #1Toxins 2012, 4 127
3.7. Ranking of Toxin Selectivity
HADDOCK is not optimised to predict absolute binding afﬁnities, and its creator (Dr. Bonvin)
has previously presented evidence that in the current iteration (HADDOCK2.1) energies are
poorly-correlated with experimental binding afﬁnities [69]. However, the geometrical properties of the
docking interface is invariant, regardless of the actual contribution of individual interactions therein.
We argue that the class of toxin-channel interactions tested in this study emphasises surface matching,
and HADDOCK can reliably produce “correct” binding modes that agree with mutagenesis data. The
general success of contact-pair prediction implies that the native well is interfacially unique and clearly
resolvable from the background of distant minima and non-speciﬁc binding. On the other hand, afﬁnity
prediction fails by the virtue of frequent detection of false-positives and poor correlation of afﬁnity and
HADDOCK energy. This implies that the accuracy of HADDOCK is insufﬁcient to accurately rank true
binding. Such is the case for NTX and Pi1 where very similar modes have been replicated across the
three channels. Of course, one should also note that arguments for selectivity can be made for toxins
where surface compatibility is channel-speciﬁc, e.g. KTx-3, HsTX1 and cobatoxin (not shown). Such
geometrical aspects of binding should be discernable in docking through a lack of clustering and/or large
changes in the binding mode location.
Can any hint of selectivity be observed? We note that electrostatics contribute to much of the
binding process due to the net charges of the docking partners, and have previously observed such
phenomena in PMF calculations [70,71]. The reaction intermediates in binding are dominated by
electrostatics and show up in docking as a cloud over a broad set of coordinates. If it can be assumed
that the absolute ’binding’ energy of these non-speciﬁc interactions are comparable across channels, then
usable information on selectivity can be derived from the energetic separation of binding minima from
the background.
It is clear from the examples presented so far that most docking-pairs exhibit binding wells (of
varying qualities) regardless of actual afﬁnity. This suggests that HADDOCK, being trained for binding
site recognition, is energetically ineffective at distinguishing the false positives from the near-native
complexes. On the other hand, a signiﬁcant portion of false complexes reveal deformations ranging
from secondary structure of toxins to quaternary structure of channel assembly, although the scale
can vary from minor distortions to gross deformations. We therefore attempted to improve minima
determinationbymanuallycullingtheun-physicalcomplexesfromtheﬁrst30complexesforacollection
of toxins (Figure 8).Toxins 2012, 4 128
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We ﬁnd that culling removes spurious outliers, selectively reduces cluster sizes, and improves
binding-well shape marginally. While this assists with cluster identiﬁcation, the overall binding-well
characteristics do not change signiﬁcantly. That is, this post-processing improves clustering
characteristics but does not improve HADDOCK’s energetic discrimination. Using indicators of
clustering, cluster-size and relative energy, a qualitative agreement with experimental afﬁnities for some
toxins can be found: AgTX2 locations favour Kv1.1 and 1.3 over Kv1.2, with fracturing of clusters
in Kv1.2 and 1.3; TsTX-K–Kv1.1 interactions show no distinctive clusters; HsTX1 and coba-1 show
larger and more favoured clusters towards their target channels; mokatoxin (moka-1) displays the largest
cluster vs. Kv1.3. On the other hand NTX, Pi1 and MTX remain as before. Results for ubiquitous
binders MgTX and HgTX1 are not predictive, but have been included to show their performance.
During culling we also noted that structural deformation tends to be more common in low-afﬁnity
channel–toxin pairs. We suspect that the ultimate source of minima arises from the limitations of
constraint-driven docking. The lack of membrane environments and artiﬁcial lowering of energetic
barriers (to improve sampling efﬁciency) leads to artiﬁcial favouring of false minima relative to the
mass of non-speciﬁc binding. In other words, during docking toxins are able to pay the costs of ﬁtting
into sub-optimal binding orientations where realistic steric and conformational barriers would otherwise
prevent this. This phenomenon can potentially be repaired by structure-quality checks (We did not utilise
HADDOCK’s native interfaces with PROCHECK in this study) or additional reﬁnement stages where
more realistic energy terms are utilised.
We also investigated the possibility that the inﬂuence of constraint-bias can be detected through
blind-docking comparisons. This was able to identify NTX–Kv1.1 as a false minima, as covered
above—the removal of constraint bias drastically decreases the actual hit ratio of non-binders. For the
rest of the toxins in this study, an approximate correlation between hit ratio and afﬁnity can sometimes
be seen, especially for KTx-3 toxins where the selectivity ratio is large. The methodology proved
inconsistent, however, when we applied blind-docking checks to other families with more complex
bindingcharacteristics. TheuseoflongMD-simulationstoproduceensemblessigniﬁcantlyimprovesthe
comparative value of blind-docking, but did not eliminate the innate limitations of docking. Despite the
increase of initial trials to 20,000 complexes to adequately sample the possible rotational arrangements,
we cannot observe with conﬁdence whether lack of binding is due to non-interaction or lack of sampling
of the binding-site. We can only conﬁrm whether our constraint choices accurately reﬂects the potential
native modes that can exist for the toxin, i.e., preservation of canonical binding. As clearly more
sampling is required to make blind-docking statistically useful, we conclude that this method is not a
cost-effective measure for systematic studies: blind-trials using 20,000 initial complexes already require
360 CPU-hours, as compared 96-CPU hours for a constrained trial with 5000 initial complexes.
3.8. Further Considerations and Extensibility of Protocol
In the interests of brevity and compatibility of interpretation, we elected to present only key toxins
from the major KTx-families—having selected only toxins that possess both experimental coordinates
and afﬁnities towards rat Kv-channels. Docking should in principle be applicable to other potassium
channels if high-quality homology models can be built. Putative binders may then be identiﬁed by
correlating functional residues across different decoys. The value of comparative docking lies inToxins 2012, 4 131
the explicit connection between sequence and function. For example, the KTx-3 binding model is
consistent across all tested members. This is a result that can be reinforced by building and testing
additional members such as Aam-KTx (3.11) [72] and OdK2 (3.12) [73]. Assuming that protocols are
sound, it should be expected that any member sharing sufﬁciently similar morphology and functional
residues should yield comparative complexes. We would caution that all homology models, of toxins
or channels, should be well-veriﬁed, e.g., tested for stability in long MD-simulations) before their
application towards docking.
Our choice of pore-Lys as a measurement precludes us from making un-biased judgements of
functional toxins that do not exhibit such a motif. It is evident in AgTX2-K27M that mutation can
remove K+-ion competition without completely abrogating current-block [66], which echos similar
alanine scan studies for other toxins. This supports the notion that other motifs are capable of supporting
a pore-occluding mode. Aside from the central motif, the toxin-channel interface also contains numerous
charge, hydrogen bond, and aromatic/sulphur interactions. It is therefore reasonable to suggest that
current block can be sustained without a favourable pore interaction. On the other hand, it is possible
that for some toxins a substitute from the basic-ring motif might form a low-afﬁnity mode. This presents
a novel interface that afﬁrms some of the spurious false-positives found above, although such modes
would remain in competition with K+-ions. Toxins from more recent families such as Tc32 (18.1) and
Tt28(20.1) may be used to investigate these possibilities.
A generalisation of the “compare and contrast” protocol in this study requires the availability of
a channel structure, a (small) collection of sequence-afﬁnity data from which to build a consensus,
and some preliminary functional information to avoid a costly blind-search of the interaction surface.
Although the correct binding mode can be resolved without assistance in the potassium channels
investigated here, we suspect that this is not generally true due to the prominence of electrostatics
within Kv-binding. Given this consideration, adaptation to other potassium channels is a matter of
homology-modelling and structural identiﬁcation of the toxins involved.
The recent publication of a bacterial voltage-gated sodium channel structure (NavAb, [74]) opens up
the possibility of adapting this work towards human Nav using corresponding selective peptides [75]. Of
its pore-blockingtoxins, analogous critical interactions suchas E758–R13 in -conotoxin [76]may serve
asasuitableconstrainttoincreasecomputationalefﬁciency. Structuresforacid-sensingionchannels[77]
also exist, although few toxins have been described thus far. A novel characterisation would involve a
combination of mutagenesis scans with comparative docking, examining the perturbation of mutant on
potential binding modes and clustering characteristics. We note that mutagenesis can also be used to
artiﬁcially increase the “variety” of pairings.
We note that a signiﬁcant fraction of known channel toxins are gating modiﬁers that bind through
voltage sensor domains. While a more complex deﬁnition of HADDOCK restraints can be constructed
to describe the interface, extension of this protocol towards such peptides are complicated by membrane
environment limitations. Nevertheless, in terms of selectivity between Kv, Nav and Cav voltage
sensors both promiscuous and narrow toxins have been found. An investigation clarifying their
structure-function relationships underlying this would be appropriate.Toxins 2012, 4 132
4. Summary
We ﬁnd that HADDOCK is adequate in identifying plausible mechanisms of binding across all of
the KTx families studied, using constrained-docking followed by analysis and clustering of docking
performance to identify putative binding conﬁgurations. This process is somewhat complicated by
the population of false minima in addition to true binding. Although the energy function reliably
separates all putative minima from obvious non-binders, the separation of false from true minima is
much more difﬁcult and will beneﬁt from some experimental knowledge of the interaction. While
determination can be guided by close inspection of complex quality, such judgements will inevitably
suffer from observer-bias. Especially in cases where the measureable binding to a Kv-subtype is blocked
only by one or two mutations, we ﬁnd parallel minima that closely resemble true binding against its
active counterpart.
Despite these shortcomings, we can nevertheless draw predictions on familial characteristics with
docking alone. HADDOCK preserves well the geometrical aspects of interactions, and by correlation
across members of the same family we can link common selectivity proﬁle with common sequence
features spotted in docking. The identiﬁcation of fundamental features also leads to analogies that can
be extended to other families that possess convergent characteristics, and increases the conﬁdence in
the interpretation of data from new toxins where validation is not yet available. With respect to detected
familial characteristics, the KTx-2 interact with conserved residues in the channel and KTx-3 with the
unique surface around the Kv1.3 turret. The evidence for partial block in KTx-6 and channel-dependent
binding modes in KTx-4 is tantalising, as HADDOCK gives testable models that can be investigated in
experiments—the theorist must wait until such is carried out.
A general application of the ‘compare and contrast’ protocol in this study requires the availability of
a channel structure, a (small) collection of sequence-afﬁnity data from which to build a consensus, and
some preliminary functional information to avoid a costly blind-search of the interaction surface.
Although the information on contacts and categorisation of functional residues are helpful,
HADDOCK is ultimately a qualitative tool. We have been unable to ﬁnd reliable correlations with
experimentalafﬁnityeitherbyclusteringorenergetics. Sometendencieshavebeenobserved, andthefact
that docking succeeds testiﬁes to an accurate reproduction of at least some properties in interaction. This
is, however, not easily extractable from the present model. It remains to be seen whether improvements
in the forceﬁeld model or intelligent re-weighting of contributors to the energy function can tease out
these connections. Where quantitative information is direly needed, we suggest that further reﬁnements
be made using more accurate computational methods, such as explicit free-energy calculations.
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